Trial intelligence / Profile preview

Crataegus Extract WS 1442 Plus Endurance Training in NYHA II Heart Failure

DRKS00000259Phase 4Completed

Sponsor
Schwabe Group
Start
Nov 2009
Countries
1
01

Overview

A Phase 4 trial of crataegus special extract WS 1442 in heart failure (HF), sponsored by Schwabe Group. Started Nov 2009; status: completed.

02

Drugs

crataegus special extract WS 1442
03

Conditions

heart failure (HF)

Beyond the preview

Go deeper on DRKS00000259.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on DRKS00000259.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call